LTIMindtree Delivers an All-Round USD Growth of 2% QoQ
17.7.2025 16:30:00 EEST | Business Wire | Press release
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the first quarter ended June 30, 2025, as approved by its Board of Directors.
“We had a promising start to the year delivering broad-based growth, expanding margins, and making significant progress on our strategic priorities. Our Fit4Future program, sales transformation efforts, and pivot to AI have enhanced agility and strengthened our ability to scale for the future. While the macroeconomic environment remains challenging, I’m confident that our disciplined execution and unwavering client focus will continue to drive our performance.”
- Venu Lambu, Chief Executive Officer and Managing Director
Key financial highlights:
Quarter ended June 30, 2025
In USD:
- Revenue at $1,153.3 million (+2.0% Q-o-Q / +5.2% Y-o-Y)
- Operating Margin (EBIT) at 14.3%, expands by 50 bps Q-o-Q
- Net profit at $147.0 million (+12.6% Q-o-Q / +8.0% Y-o-Y)
In INR:
- Revenue at Rs. 98,406 million (+0.7% Q-o-Q / +7.6% Y-o-Y)
- Net profit at Rs. 12,546 million (+11.2% Q-o-Q / +10.5% Y-o-Y)
Other highlights:
Clients:
- 741 active clients as of June 30, 2025
- $1 million+ clients increased by 14 on a Y-o-Y basis, total 404
- $5 million+ clients increased by 11 on a Y-o-Y basis, total 159
- $10 million+ clients increased by 3 on a Y-o-Y basis, total 90
- $50 million+ clients increased by 2 on a Y-o-Y basis, total 14
People:
- 83,889 professionals as of June 30, 2025
- Trailing 12-month attrition was 14.4%
- Utilization (ex-trainees) at 88.1%
Deal Wins
- A global agribusiness leader selected LTIMindtree to implement an AI-driven model for application management, infrastructure support, and cybersecurity services. This suite of IT services includes SAP S/4HANA, ServiceNow, Microsoft Azure, and AI frameworks and focuses on efficiency and growth, driven by vendor consolidation.
- A global leader in professional services has chosen LTIMindtree as part of their supplier consolidation initiative spanning Client Technology, Enterprise Technology, and Information Security.
- A major European financial institution chose LTIMindtree as its long-term transformation partner to migrate from a legacy system to a flagship Transaction Processing Platform, integrating Gen AI and automation in the solution to accelerate delivery.
- Selected as a strategic partner by a leading digital company in the Middle East to manage their supply chain and digital landscape.
- A major utility company has engaged LTIMindtree to support the management and integration of applications across multiple ERP systems.
- A foreign government organisation has entrusted LTIMindtree with implementing a digital transformation initiative to overhaul its tax system and modernize the tax administration process.
- A leading recycling organisation in the Nordics has chosen LTIMindtree for a Managed service deal.
- A leading US-based Oil & Gas major has entrusted LTIMindtree with a multi-delivery contract to cater across Cloud, Data, SAP, and AI services.
Partnerships
- LTIMindtree was honored with the “Diversity in Security” award at the 2025 Microsoft Security Excellence Awards event, organized by the MISA. This award emphasizes the company’s dedication to promoting inclusive security teams and providing innovative security solutions seamlessly integrated with Microsoft technology for clients around the world.
- LTIMindtree was honored to be named “Google Partner of the Year 2025 for Industry Solutions in Manufacturing” for the second year in a row.
- LTIMindtree has been named a premier partner for AWS’s RAPID GenAI assessment program. The program covers use case validation, data security, performance testing, migration, and integration, enabling faster deployment and co-investment in pre-sales.
- LTIMindtree has been named the “2025 Databricks Business Transformation Partner” of the Year. Presented at the annual Data + AI Summit, the award highlights LTIM’s exceptional contributions to driving data and AI-led transformation across industries.
- LTIMindtree is recognized as the “FY25 India Partner of the Year” by Boomi. As a valued Boomi partner, LTIMindtree has been instrumental in assisting joint customers in optimizing their business operations through Agentic AI, intelligent connectivity, and automation solutions.
- At the annual Snowflake Summit 2025, LTIMindtree was honored with the “Manufacturing & Industrials Data Cloud Services Partner of the Year” award by Snowflake, the AI Data Cloud company.
Recognitions
- LTIMindtree positioned as a Leader in ISG’s Provider Lens™ SAP Ecosystem 2025 for ‘RISE with SAP Implementation’ and ‘SAP Business AI & BTP services’ globally.
- LTIMindtree positioned as a Leader in ISG’s Provider Lens™ Evaluation for Duck Creek Services Ecosystem 2025.
- LTIMindtree recognized as a Leader in HFS Horizons: Energy & Utilities Service Providers, 2025.
- LTIMindtree recognized as a Leader in Everest Group: Talent Readiness for Next-Gen Application Services PEAK Matrix® Assessment 2025.
- LTIMindtree recognized as Major Contenders in Everest Group: Microsoft Modern Work Services PEAK Matrix® Assessment 2025.
- LTIMindtree recognized as Major Contenders in Everest Group: Intelligent Process Automation Solutions PEAK Matrix® Assessment 2025.
- LTIMindtree recognized as Major Contenders in Everest Group: Life Sciences Enterprise Platform Services PEAK Matrix® Assessment 2025.
- LTIMindtree recognized as Major Contenders in Everest Group: Healthcare Data, Analytics and AI Services PEAK Matrix® Assessment 2025.
- LTIMindtree recognized as Major Contenders in Everest Group: Life Sciences Digital Services PEAK Matrix® Assessment 2025.
- LTIMindtree recognized as a Disruptor in HFS Horizons: Insurance Services, 2025.
About LTIMindtree
LTIMindtree is a global technology consulting and digital solutions company that enables enterprises across industries to reimagine business models, accelerate innovation, and maximize growth by harnessing digital technologies. As a digital transformation partner to more than 700 clients, LTIMindtree brings extensive domain and technology expertise to help drive superior competitive differentiation, customer experiences, and business outcomes in a converging world. Powered by 83,000+ talented and entrepreneurial professionals across more than 40 countries, LTIMindtree — a Larsen & Toubro Group company — solves the most complex business challenges and delivers transformation at scale. For more information, please visit https://www.ltimindtree.com/.
Earnings Conference Call
Date | Thursday, July 17, 2025 |
Time | 18:00 hours IST |
Format | Brief management discussion followed by Q&A |
Registration Link |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250717532426/en/
Contacts
Media Relations:shambhavi.revandkar@ltimindtree.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom